Xuesaitong soft is named as an intervention in 2 current clinical trials in our China register. 1 is recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is Xiyuan Hospital of China Academy of Chinese Medical Sciences (1). The most-studied condition is Acute Coronary Syndrome.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease
NCT06425120 · ClinicalTrials.gov ↗ · Coronary Heart Disease
|
Phase 4 | Recruiting | China National Center for Cardiovascular Diseases | China |
|
Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol
NCT06845254 · ClinicalTrials.gov ↗ · Acute Coronary Syndrome
|
Phase 3 | Not yet open | Xiyuan Hospital of China Academy of Chinese Medical Sciences | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Xiyuan Hospital of China Academy of Chinese Medical Sciences | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our China register name Xuesaitong soft as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Xiyuan Hospital of China Academy of Chinese Medical Sciences (1) and China National Center for Cardiovascular Diseases (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Xuesaitong soft works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Xuesaitong soft works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Xuesaitong soft (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.